206
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Incidence and Clinical Pattern of Mixed Connective Tissue Disease in Sudanese Patients at Omdurman Military Hospital: Hospital-Based Study

, ORCID Icon, , , , , , & show all
Pages 333-341 | Published online: 09 Dec 2021

References

  • Marwa K, Anjum F. Undifferentiated Connective Tissue Disease. Treasure Island (FL): StatPearls; 2021.
  • Radin M, Rubini E, Cecchi I, et al. Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. Clin Exp Rheumatol. 2021. PubMed PMID: 34251309.
  • Yoo H, Hino T, Han J, et al. Connective tissue disease- related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): evolving concept of CT findings, pathology and management. Eur J Radiol Open. 2021;8:100311. PubMed PMID: 33364263. Pubmed Central PMCID: PMC7750149. doi:10.1016/j.ejro.2020.100311
  • Miao C, Wang X, Zhou W, Huang J. The emerging roles of exosomes in autoimmune diseases, with special emphasis on microRNAs in exosomes. Pharmacol Res. 2021;169:105680. PubMed PMID: 34010670. doi:10.1016/j.phrs.2021.105680
  • Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum. 1999;42(5):899–909. PubMed PMID: 10323445. doi:10.1002/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L
  • Fernandez-Gutierrez B, Leon L, Madrid A, et al. Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents. Ther Adv Musculoskelet Dis. 2021;13:1759720X20962692. PubMed PMID: 33613703. Pubmed Central PMCID: PMC7869066. doi:10.1177/1759720X20962692
  • Ungprasert P, Crowson CS, Chowdhary VR, Ernste FC, Moder KG, Matteson EL. Epidemiology of mixed connective tissue disease, 1985–2014: a Population-Based Study. Arthritis Care Res. 2016;68(12):1843–1848. PubMed PMID: 26946215. Pubmed Central PMCID: PMC5426802. doi:10.1002/acr.22872
  • Hetlevik SO, Flato B, Rygg M, et al. Long-term outcome in juvenile-onset mixed connective tissue disease: a nationwide Norwegian study. Ann Rheum Dis. 2017;76(1):159–165. PubMed PMID: 27283334. doi:10.1136/annrheumdis-2016-209522
  • Latuskiewicz-Potemska J, Zygmunt A, Biernacka-Zielinska M, Stanczyk J, Smolewska E. Mixed connective tissue disease presenting with progressive scleroderma symptoms in a 10-year-old girl. Postepy Dermatol Alergol. 2013;30(5):329–336. PubMed PMID: 24353496. Pubmed Central PMCID: PMC3858664. doi:10.5114/pdia.2013.38365
  • Chen R, Wang J, Xie Q, Xue J, Hao C. Sjogren’s syndrome complicated with membranous nephropathy, a cause or coincidence? Int J Rheum Dis. 2021;24(8):1086–1347. PubMed PMID: 34223708. doi:10.1111/1756-185X.14168
  • Hanset N, Ronco P, Plaisier E. [Membranous nephropathy]. Rev Prat. 2021;71(1):85–89. French. PubMed PMID: 34160953.Glomerulonephrite extramembraneuse.
  • Nishizawa K, Yamashita T, Ogawa Y, Kobayashi H. Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review. CEN Case Rep. 2021. PubMed PMID: 34287815. doi:10.1007/s13730-021-00630-w
  • Koeks Z, Bladen CL, Salgado D, et al. Clinical outcomes in Duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database. J Neuromuscul Dis. 2017;4:4.306–293. PubMed PMID: 29125504. Pubmed Central PMCID: PMC5701764.
  • Ahsan T, Erum U, Dahani A, Khowaja D. Clinical and immunological profile in patients with mixed connective tissue disease. J Pak Med Assoc. 2018;68(6):959–962. PubMed 359 PMID: 30323370.
  • Nedumaran RCP, Porkodi R, Parthiban R. Mixed connective tissue disease– clinical and immunological profile. J Assoc Physicians India. 2001;49:412–414. PubMed 362 PMID: 11762609.
  • John KJ, Sadiq M, George T, et al. Clinical and immunological profile of mixed connective tissue disease and a comparison of four diagnostic criteria. Int J Rheumatol. 2020;2020:9692030. PubMed PMID: 32411251. Pubmed Central PMCID: PMC7204172. doi:10.1155/2020/9692030
  • Wiefel K, Aringer M. [Polyarthritis - from symptoms to diagnosis]. Polyarthritiden – vom Symptom zur Diagnose. Dtsch Med Wochenschr. 2021;146(9):582–590. German. PubMed PMID: 33931836. doi:10.1055/a-1294-1205
  • Michotte L. [The differential diagnosis of polyarthritis]. Le diagnostic differentiel des polyarthrites. Acta Physiother Rheumatol Belg. 1947;2(1):11–20. Swedish. PubMed PMID: 20247629.
  • Alpay-Kanitez N, Celik S, Bes C. Polyarthritis and its differential diagnosis. Eur J Rheumatol. 2019;6(4):167–173. PubMed PMID: 31657698. Pubmed Central PMCID: 375 PMC6.812894. doi:10.5152/eurjrheum.2019.19145
  • Kundi M, Assad S, Babar S, et al. Mixed connective tissue disorder complicated by polymyositis, sjogren’s syndrome, pleural effusion and pericarditis. Cureus. 2016;8(12):e906. PubMed PMID: 28083450. Pubmed Central PMCID: PMC5208556. doi:10.7759/cureus.906
  • Institue of Medicine (US) Committee on multiple sclerosis: current status and strategies for the the future. Joy JE, Johnston RB Jr, editors. Washington (DC): national academies press (us); 2001. PMID:25057543.
  • Lokesh L, Tony K, Raghupathy R, V S, Malepati B. A rare case of Mixed Connective Tissue Disease (MCTD) with intricate features of lupus, polymyositis and rheumatoid arthritis presenting with severe myositis. J Clin Diagn Res. 2015;9(3):OD05–OD07. PubMed PMID: 25954655. Pubmed Central PMCID: PMC4413104. doi:10.7860/JCDR/2015/11575.5695
  • Carnero-Montoro E, Barturen G, Povedano E, et al. Epigenome-Wide Comparative Study reveals key differences between mixed connective tissue disease and related systemic autoimmune diseases. Front Immunol. 2019;10:1880. PubMed PMID: 31440254. Pubmed Central PMCID: PMC6693476. doi:10.3389/fimmu.2019.01880
  • Missounga L, Ba JI, Nseng nseng ondo IR, et al. [Mixed connective tissue disease: prevalence and clinical characteristics in African black, study of 7 cases in Gabon and review of the literature]. La connectivite mixte: prevalence et caracteristiques cliniques chez le noir africain, etude de 7 cas au Gabon et revue de la litterature. Pan Afr Med J. 2017;27:162. French. PubMed PMID: 28904690. Pubmed Central PMCID: PMC5567953. doi:10.11604/pamj.2017.27.162.12572
  • Nagaraja V, McMahan ZH, Getzug T, Khanna D. Management of gastrointestinal involvement in scleroderma. Curr Treat Options Neurol. 2015;1(1):82–105. PubMed PMID: 26005632. Pubmed Central PMCID: PMC4437639. doi:10.1007/s40674-014-0005-0
  • Xu ZY, Li QQ, Zhang C, Zhang HS, Gu H. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48(4):315–322. Chinese. PubMed PMID: 32370483. doi:10.3760/cma.j.cn112148-20190628-00364
  • Didier K, Bolko L, Giusti D, et al. Autoantibodies associated with connective tissue diseases: what meaning for clinicians? Front Immunol. 2018;9:541. PubMed PMID: 29632529. Pubmed Central PMCID: PMC5879136. doi:10.3389/fimmu.2018.00541
  • Cozzani E, Agnoletti AF, Pappalardo F, Schiavetti I, Torino A, Parodi A. The high incidence of anti-Ro/SSA and anti-p200 antibodies in female patients with connective tissue diseases confirms the importance of screening for congenital heart block-associated autoantibodies during pregnancy. Arch Dermatol Res. 2016;308(2):139–143. PubMed 410 PMID: 26830903. doi:10.1007/s00403-016-1622-2
  • Wilson H. Biomarkers in autoimmune rheumatic diseases. Biomark Med. 2015;9(6):497–498. PubMed PMID: 26079956. doi:10.2217/bmm.15.27
  • Giacomelli R, Afeltra A, Alunno A, et al. Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis. Autoimmun Rev. 2019;18(1):93–106. PubMed PMID: 30408582. doi:10.1016/j.autrev.2018.08.003
  • Amissah-Arthur MB, Gordon C. Contemporary treatment of systemic lupus erythematosus: an update for clinicians. Ther Adv Chronic Dis. 2010;1(4):163–175. PubMed PMID: 23251736. Pubmed Central PMCID: PMC3513867. doi:10.1177/2040622310380100